ABC² (Accelerate Brain Cancer Cure)

Brain cancer breakthroughs don't follow conventional wisdom. Neither do we.

73.69

1717 Rhode Island Avenue, NW Suite 700
Washington, DC 20036
tel: (202) 419-3140 Web Site
EIN: 52-2320756

Board Leadership
Steve Case
Chair

CEO
Max Wallace
Chief Executive Officer

The data displayed on this tab is provided by the IRS in the form of Publication 78 and the Business Master File (BMF).

EIN	52-2320756
Name in IRS Master File	ABC² (Accelerate Brain Cancer Cure)
NTEE Code	[Not Provided by IRS]
NTEE Classification	[Not Provided by IRS]
NTEE Type	[Not Provided by IRS]
Classification
Subsection	(View the list of codes)
Activities
Foundation Status
Deductibility
Affiliation
Group Name	[Not Applicable]
Filing Requirement
Fiscal Year End
IRS Forms 990 (provided courtesy of Foundation Center)	(Log In or Register Now to View Forms 990!) December, 2017 December, 2016 December, 2015 December, 2014 December, 2013

ABC² (Accelerate Brain Cancer Cure)
1717 Rhode Island Avenue, NW
Suite 700
Washington, DC 20036
tel: (202) 419-3140
EIN: 52-2320756

Steve Case
Chair

Max Wallace
Chief Executive Officer